207 related articles for article (PubMed ID: 32512568)
1. Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.
Mangili F; Giardino E; Treppiedi D; Barbieri AM; Catalano R; Locatelli M; Lania AG; Spada A; Arosio M; Mantovani G; Peverelli E
Neuroendocrinology; 2021; 111(6):568-579. PubMed ID: 32512568
[TBL] [Abstract][Full Text] [Related]
2. DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
Mangili F; Esposito E; Treppiedi D; Catalano R; Marra G; Di Muro G; Barbieri AM; Locatelli M; Lania AG; Mangone A; Spada A; Arosio M; Peverelli E; Mantovani G
Front Endocrinol (Lausanne); 2022; 13():867822. PubMed ID: 35721701
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.
Mangili F; Treppiedi D; Catalano R; Marra G; Di Muro G; Spada A; Arosio M; Peverelli E; Mantovani G
Front Endocrinol (Lausanne); 2020; 11():611752. PubMed ID: 33664708
[TBL] [Abstract][Full Text] [Related]
4. A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.
Di Muro G; Mangili F; Esposito E; Barbieri AM; Catalano R; Treppiedi D; Marra G; Nozza E; Lania AGA; Ferrante E; Locatelli M; Arosio M; Peverelli E; Mantovani G
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370829
[TBL] [Abstract][Full Text] [Related]
5. Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary.
Recouvreux MV; Guida MC; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2011 Jul; 152(7):2722-30. PubMed ID: 21521749
[TBL] [Abstract][Full Text] [Related]
6. The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment.
Liu YT; Liu F; Cao L; Xue L; Gu WT; Zheng YZ; Tang H; Wang Y; Yao H; Zhang Y; Xie WQ; Ren BH; Xiao ZH; Nie YJ; Hu R; Wu ZB
Acta Neuropathol; 2020 Sep; 140(3):377-396. PubMed ID: 32572597
[TBL] [Abstract][Full Text] [Related]
7. The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
Di Muro G; Catalano R; Treppiedi D; Barbieri AM; Mangili F; Marra G; Di Bari S; Esposito E; Nozza E; Lania AG; Ferrante E; Locatelli M; Modena D; Steinkuhler C; Peverelli E; Mantovani G
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612419
[TBL] [Abstract][Full Text] [Related]
8. Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.
Peverelli E; Mantovani G; Vitali E; Elli FM; Olgiati L; Ferrero S; Laws ER; Della Mina P; Villa A; Beck-Peccoz P; Spada A; Lania AG
J Clin Endocrinol Metab; 2012 Mar; 97(3):967-77. PubMed ID: 22259062
[TBL] [Abstract][Full Text] [Related]
9. Exploiting D
Tan Z; Lei Z; Yan Z; Ji X; Chang X; Cai Z; Lu L; Qi Y; Yin X; Han X; Lei T
Br J Pharmacol; 2021 Sep; 178(17):3570-3586. PubMed ID: 33904172
[TBL] [Abstract][Full Text] [Related]
10. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
Ishida M; Mitsui T; Izawa M; Arita J
Mol Cell Endocrinol; 2013 Aug; 375(1-2):58-67. PubMed ID: 23701824
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Receptors in Nonfunctioning Pituitary Neuroendocrine Tumors: Review on Expression and Gonadotroph Functions.
Haydar Ali Tajuddin A; Kamaruddin N; Sukor N; Azizan EA; Omar AM
J Endocr Soc; 2020 Dec; 4(12):bvaa157. PubMed ID: 33241169
[TBL] [Abstract][Full Text] [Related]
12. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms.
Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G
J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227
[TBL] [Abstract][Full Text] [Related]
13. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours.
Rai A; Yelamanchi SD; Radotra BD; Gupta SK; Mukherjee KK; Tripathi M; Chhabra R; Ahuja CK; Kumar N; Pandey A; Korbonits M; Dutta P; Gaston-Massuet C
Acta Neuropathol Commun; 2022 Sep; 10(1):138. PubMed ID: 36114575
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation.
Peverelli E; Giardino E; Treppiedi D; Locatelli M; Vaira V; Ferrero S; Bosari S; Lania AG; Spada A; Mantovani G
Cancer Lett; 2016 Oct; 381(2):279-86. PubMed ID: 27519461
[TBL] [Abstract][Full Text] [Related]
16. Functional Toll-like receptor 4 expressed in lactotrophs mediates LPS-induced proliferation in experimental pituitary hyperplasia.
Sabatino ME; Sosa Ldel V; Petiti JP; Mukdsi JH; Mascanfroni ID; Pellizas CG; Gutiérrez S; Torres AI; De Paul AL
Exp Cell Res; 2013 Nov; 319(19):3020-34. PubMed ID: 23973924
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.
Wen S; Li J; Yang J; Li B; Li N; Zhan X
Front Endocrinol (Lausanne); 2021; 12():753606. PubMed ID: 34712204
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.
Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G
J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3.
Zhu J; Hu Z; Han X; Wang D; Jiang Q; Ding J; Xiao M; Wang C; Lu M; Hu G
Cell Death Differ; 2018 Nov; 25(11):2037-2049. PubMed ID: 29786071
[TBL] [Abstract][Full Text] [Related]
20. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]